Author: Marshall Beck

Study finds asthma & food allergies predictable at age 1

A press release issued by The Journal of Allergy and Clinical Immunology (JACI) highlights new findings from AllerGen’s CHILD Study that will help doctors better predict which children will develop asthma and allergies. Analyzing data from more than 2,300 children

Stress in pregnancy may affect a baby’s immune system

Infants born to mothers experiencing distress may be at a higher risk of developing allergic disease, according to new findings published online in Brain, Behavior and Immunity. The study analyzed data from 403 infants and their mothers participating in AllerGen’s

Asthma risk lower with direct breastfeeding: CHILD Study

Direct breastfeeding in the first three months of life appears to provide more protection against childhood asthma than either infant formula or expressed breastmilk, according to new findings from AllerGen’s CHILD Study. The researchers analyzed data from 2,534 infants who

New genetic clue to peanut allergy

AllerGen researchers have pinpointed a new gene associated with peanut allergy. The gene, c11orf30/EMSY, is already known to play a role in other allergy-related conditions, such as eczema, asthma, and allergic rhinitis. This study is the first to associate the

Dr. Brett Finlay inducted into Canadian Medical Hall of Fame

AllerGen investigator Dr. Brett Finlay (The University of British Columbia) is one of six 2018 inductees to the Canadian Medical Hall of Fame. Laureates of this honour are individuals whose contributions to medicine and the health sciences have led to

CIC-tested biologic poised to become a “game-changing, blockbuster” asthma drug

In 2014, AllerGen’s Clinical Investigator Collaborative (CIC) conducted an early Phase II clinical trial on the injectable biologic drug tezepelumab, developed by MedImmune (the biologics arm of AstraZeneca) and Amgen, and first identified the drug’s significant therapeutic potential. “Now, it’s

AllerGen researcher featured in CIHR breastfeeding panel

On August 2, 2017, AllerGen investigator Dr. Meghan Azad (University of Manitoba) participated in a panel discussion organized by the CIHR’s Institute of Human Development, Child & Youth Health (IHDCYH) on breastfeeding and children’s health. In the event, Dr. Azad

New faces on CHILD administrative team

Autumn has brought change to the administrative ranks of the CHILD Study. As of September 1, 2017, the Manitoba site has a new Research Coordinator, and as of September 8, 2017, CHILD Toronto has a new Site Leader. Dr. Theo

Breastmilk hormones may help prevent obesity in infants

For years, scientists have attempted to understand the complexities of human milk—what it’s made of, how it’s produced, and how its unique composition affects an infant’s growth and development. In a new study published in the International Journal of Obesity,

Protecting against peanut allergy in children: new findings

Eating peanut while breastfeeding and early peanut introduction may help protect against peanut allergy in children, according to a new study led by researchers at the Children’s Hospital Research Institute of Manitoba and the University of Manitoba and published in

Remembering Michelle Harkness

With profound sadness, we confirm that Michelle Harkness, AllerGen’s Manager, Highly Qualified Personnel (HQP) Training and Events, and a longtime colleague and friend, passed away on August 22, 2017, following a brief illness. Michelle managed AllerGen’s HQP program with passion

Canadian allergists/immunologists comment on recent Australian oral immunotherapy study

AllerGen investigators Drs Manel Jordana and Susan Waserman and AllerGen HQP Dr. Derek Chu have prepared a statement in response to a recent Australian study being heralded as a “breakthrough” and a “cure” for peanut allergy. The paper, published in

Top